Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
โ‚ฌ3.97 M
Marketcap
0,30ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -114,15ย โ‚ฌ

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -106,50ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -7,45ย โ‚ฌ an increase over its 2020 EPS that were of -9,84ย โ‚ฌ.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-114,15ย โ‚ฌ
2021-7,45ย โ‚ฌ-24.31%
2020-9,84ย โ‚ฌ-5.41%
2019-10,41ย โ‚ฌ-72.67%
2018-38,08ย โ‚ฌ-291.46%
201719,89ย โ‚ฌ797.22%
20162,22ย โ‚ฌ-34.03%
20153,36ย โ‚ฌ-207.61%
2014-3,12ย โ‚ฌ-366.73%
20131,17ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
12,39ย โ‚ฌ-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,76ย โ‚ฌ-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
7,52ย โ‚ฌ-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA